892390-30-6 Usage
Description
(R)-tert-butyl 3-(ethylamino)pyrrolidine-1-carboxylate is a chiral chemical compound that belongs to the class of pyrrolidine carboxylic acid derivatives. It is a derivative of pyrrolidine and contains a tert-butyl group, an ethylamino group, and a carboxylate group. (R)-tert-butyl 3-(ethylamino)pyrrolidine-1-carboxylate is commonly used in organic synthesis and pharmaceutical research as a building block for the preparation of various bioactive molecules and pharmaceutical drugs. Its unique structural features also make it a promising candidate for the development of new materials and chemical processes.
Uses
Used in Pharmaceutical Research:
(R)-tert-butyl 3-(ethylamino)pyrrolidine-1-carboxylate is used as a building block in pharmaceutical research for the preparation of various bioactive molecules and pharmaceutical drugs. Its unique structural features and chiral nature make it a valuable component in the development of new drugs with improved efficacy and selectivity.
Used in Organic Synthesis:
(R)-tert-butyl 3-(ethylamino)pyrrolidine-1-carboxylate is used as a key intermediate in organic synthesis for the preparation of a wide range of chemical compounds. Its versatile functional groups, such as the tert-butyl, ethylamino, and carboxylate groups, allow for various synthetic transformations and the formation of complex molecular architectures.
Used in the Development of New Materials:
(R)-tert-butyl 3-(ethylamino)pyrrolidine-1-carboxylate is used in the development of new materials due to its unique structural features. Its chiral nature and functional groups can be exploited to create novel materials with specific properties, such as chiral catalysts, enantioselective sensors, or chiral stationary phases for chromatographic separations.
Used in Chemical Processes:
(R)-tert-butyl 3-(ethylamino)pyrrolidine-1-carboxylate has potential applications in the development of new chemical processes. Its versatile functional groups can be utilized in various chemical reactions, such as esterification, amidation, or alkylation, to produce new compounds or improve existing synthetic routes. This can lead to more efficient and environmentally friendly chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 892390-30-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,2,3,9 and 0 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 892390-30:
(8*8)+(7*9)+(6*2)+(5*3)+(4*9)+(3*0)+(2*3)+(1*0)=196
196 % 10 = 6
So 892390-30-6 is a valid CAS Registry Number.
892390-30-6Relevant articles and documents
Discovery of a novel bicyclic compound, DS54360155, as an orally potent analgesic without mu-opioid receptor agonist activity
Arita, Tsuyoshi,Asano, Masayoshi,Kubota, Kazufumi,Domon, Yuki,Machinaga, Nobuo,Shimada, Kousei
supporting information, (2019/11/11)
We synthesized derivatives of a natural alkaloid, conolidine, and evaluated these derivatives in the acetic acid-induced writhing test and formalin test in ddY mice after oral administration. As a result, we identified (5S)-6-methyl-1,3,4,5,6,8-hexahydro-7H-2,5-methano[1,5]diazonino[7,8-b]indol-7-one sulfate salt, 15a (DS54360155), with a unique and original bicyclic skeleton, as an analgesic more potent than conolidine. Moreover, 15a did not exhibit mu-opioid receptor agonist activity.
3-amino nafoxidine-containing quinazoline ketone PARP (Poly Adenosine Diphosphate Ribose Polymerase)-1/2 inhibitor as well as preparation method, medicinal composition and application thereof
-
, (2018/11/22)
The invention discloses a novel 3-amino nafoxidine-containing quinazoline-2,4(1H, 3H)-diketone PARP-1/2 (Poly Adenosine Diphosphate Ribose Polymerase) inhibitor as well as a preparation method, a medicinal composition and application thereof. Specifically, the invention relates to a 3-amino nafoxidine-containing quinazoline-2,4(1H, 3H)-diketone derivative and a medicinal salt thereof of formula (I) as shown in the specification, a preparation method thereof, a composition with one or more such compounds, preparation of the compounds, and application thereof in preparing medicines for preventing and/or treating PARP-1/2 related diseases.
